Predictors of visual and anatomical outcomes for neovascular age-related macular degeneration treated with bevacizumab.

Ma, Chaoran; Bai, Liang; Lei, Chunling; Wu, Changrui; Shi, Qiang; Hu, Feng; Hao, Zhenxuan; Ma, L E.

Afiliação

Ma C; Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Bai L; Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Lei C; The Fourth Hospital of Xi'an, Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China.
Wu C; The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Shi Q; The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Hu F; Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Hao Z; Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Ma LE; Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

Biomed Rep ; 3(4): 503-508, 2015 Jul.

Article em En | MEDLINE | ID: mdl-26171156